Cargando…
Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
Background: Chemotherapy is one of the most common therapies used in the treatment of colorectal cancer (CRC), but chemoresistance inevitably occurs. It is challenging to obtain an immediate and accurate diagnosis of chemoresistance. The potential of circulating exosomal miRNAs as oxaliplatin-based...
Autores principales: | Han, Jiayi, Sun, Wu, Liu, Rui, Zhou, Zhen, Zhang, Haiyang, Chen, Xi, Ba, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531016/ https://www.ncbi.nlm.nih.gov/pubmed/33072545 http://dx.doi.org/10.3389/fonc.2020.01495 |
Ejemplares similares
-
Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022) -
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023) -
Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
por: Ning, Tao, et al.
Publicado: (2021) -
Evaluation of the Diagnostic Potential of a Plasma Exosomal miRNAs Panel for Gastric Cancer
por: Yang, Jiajia, et al.
Publicado: (2021)